Forgotten but not gone: new developments in the understanding and treatment of tardive
dyskinesia (TD) can occur in up to 20% of schizophrenia patients receiving long-term antipsychotics (APs) [1-4], and is associated with considerable personal suffering and social and physical disabilities.
In a statement, Mitchell Mathis, MD, director of the FDA's division of psychiatry products in the Center for Drug Evaluation and Research, praised the approval as "an important advance for patients suffering with tardive
dyskinesia is frequently associated with first generation neuroleptics, these medications should be used restrictively only in major mental disorder and also doses should be kept low.
Lower risk for tardive
dyskinesia associated with secondgeneration antipsychotics: A systematic review of 1-year studies.
The report provides a snapshot of the global therapeutic landscape of Tardive
We believe the application of Auspex's deuterium platform to known pharmaceuticals holds great promise across a wide spectrum of neurological diseases and associated movement disorders, including Huntington's disease, tardive
dyskinesia and Tourette syndrome," said Michael Hayden, Teva's president of global R&D and chief scientific officer.
Morningside's investment in Synchroneuron demonstrates our belief in the potential of SNC-102 to safely and effectively treat neuropsychiatric disorders such as tardive
dyskinesia as well as its potential in additional indications, said Gerald Chan, Chairman of Morningside Technology Ventures.
Recognition and differential diagnosis of tardive
announced today the firm is now accepting cases on behalf of people who used the prescription drug Reglan and later developed tardive
dyskinesia, a neurological disorder that causes uncontrollable, repetitive movements of the body, such as grimacing, lip smacking, eye blinking or rapid leg and arm movements.
My gran was given the wrong pills some years ago and has been left with tardive
A boxed warning about an increased risk of tardive
dyskinesia associated with the chronic use of metoclopramide will be added to the drug's label, according to the Food and Drug Administration.